Unity Biotechnology, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2017 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Unity Biotechnology, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2017 to Q3 2024.
  • Unity Biotechnology, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$6.48M, a 56.2% increase year-over-year.
  • Unity Biotechnology, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$21.9M, a 49% increase year-over-year.
  • Unity Biotechnology, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$39.9M, a 10.4% increase from 2022.
  • Unity Biotechnology, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$44.5M, a 26.8% increase from 2021.
  • Unity Biotechnology, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$60.7M, a 35.3% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$21.9M -$6.48M +$8.3M +56.2% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-04
Q2 2024 -$30.2M -$5.28M +$10.2M +65.8% Apr 1, 2024 Jun 30, 2024 10-Q 2024-11-04
Q1 2024 -$40.4M -$5.79M -$511K -9.68% Jan 1, 2024 Mar 31, 2024 10-Q 2024-11-04
Q4 2023 -$39.9M -$4.34M +$3.08M +41.5% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-15
Q3 2023 -$42.9M -$14.8M -$9.79M -196% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-04
Q2 2023 -$33.2M -$15.5M -$2.32M -17.7% Apr 1, 2023 Jun 30, 2023 10-Q 2024-11-04
Q1 2023 -$30.8M -$5.28M +$13.6M +72.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-11-04
Q4 2022 -$44.5M -$7.42M +$3.27M +30.6% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-15
Q3 2022 -$47.7M -$5M +$11.5M +69.6% Jul 1, 2022 Sep 30, 2022 10-K 2024-04-15
Q2 2022 -$59.2M -$13.1M +$4.69M +26.3% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-13
Q1 2022 -$63.9M -$18.9M -$3.16M -20.1% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-13
Q4 2021 -$60.7M -$10.7M +$8.89M +45.4% Oct 1, 2021 Dec 31, 2021 10-K 2024-04-15
Q3 2021 -$69.6M -$16.5M +$11.1M +40.3% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 -$80.7M -$17.8M +$841K +4.51% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-08
Q1 2021 -$81.6M -$15.8M +$12.3M +43.8% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-08
Q4 2020 -$93.8M -$19.6M -$1.56M -8.65% Oct 1, 2020 Dec 31, 2020 10-K 2021-03-23
Q3 2020 -$92.3M -$27.6M -$5.84M -26.9% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 -$86.4M -$18.7M +$5.01M +21.1% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-10
Q1 2020 -$91.4M -$28M -$9.27M -49.4% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-10
Q4 2019 -$82.2M -$18M +$3.89M +17.7% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-23
Q3 2019 -$86.1M -$21.7M -$3.36M -18.3% Jul 1, 2019 Sep 30, 2019 10-K 2021-03-23
Q2 2019 -$82.7M -$23.7M -$3.67M -18.4% Apr 1, 2019 Jun 30, 2019 10-K 2021-03-23
Q1 2019 -$79M -$18.8M -$2.63M -16.3% Jan 1, 2019 Mar 31, 2019 10-K 2021-03-23
Q4 2018 -$76.4M -$21.9M -$9.37M -74.7% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-11
Q3 2018 -$67M -$18.3M -$6.6M -56.1% Jul 1, 2018 Sep 30, 2018 10-K 2020-03-11
Q2 2018 -$60.4M -$20M -$8.57M -75% Apr 1, 2018 Jun 30, 2018 10-K 2020-03-11
Q1 2018 -$51.9M -$16.1M -$7.2M -80.6% Jan 1, 2018 Mar 31, 2018 10-K 2020-03-11
Q4 2017 -$44.7M -$12.5M Oct 1, 2017 Dec 31, 2017 10-K 2019-03-06
Q3 2017 -$11.8M Jul 1, 2017 Sep 30, 2017 10-K 2019-03-06
Q2 2017 -$11.4M Apr 1, 2017 Jun 30, 2017 10-K 2019-03-06
Q1 2017 -$8.93M Jan 1, 2017 Mar 31, 2017 10-K 2019-03-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.